SEC Form 4 · accession 0000899243-19-004306
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott A. Kelly
Director
Period of report
Feb 16, 2019
Accepted (ET)
Feb 20, 2019 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1 | $0.51 | Feb 16, 2019 | A | 500,000 | A | — | Feb 16, 2029 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The warrant will vest in four equal quarterly installments commencing on May 16, 2019.